Hyperion DeFi, Inc. (HYPD)
3.40
+0.04
(+1.04%)
USD |
NASDAQ |
Oct 09, 16:00
3.41
+0.01
(+0.29%)
After-Hours: 20:00
Hyperion DeFi Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -8.01K% |
| September 30, 2025 | |
| June 30, 2025 | |
| March 31, 2025 | -23.70K% |
| December 31, 2024 | -71.01K% |
| September 30, 2024 | -493.0K% |
| June 30, 2024 | -48.91K% |
| March 31, 2024 | -218.4K% |
| December 31, 2023 | -306.4K% |
| September 30, 2023 | -611.6K% |
| June 30, 2023 |
| Date | Value |
|---|---|
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 29.83% |
| September 30, 2021 | |
| June 30, 2021 | -242.1% |
| March 31, 2021 | -267.6% |
| December 31, 2020 | -210.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Omeros Corp. | 23.26% |
| Talphera, Inc. | -- |
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 10.74% |
| Return on Assets | 8.91% |
| Return on Invested Capital | 9.42% |
| Operating Margin (Quarterly) | -757.5% |
| Return on Net Operating Assets | 25.80% |